Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

National Research (NRC) EBITDA Margin: 2009-2024

Historic EBITDA Margin for National Research (NRC) over the last 16 years, with FY2024 value amounting to 24.6%.

  • National Research's EBITDA Margin rose 800.0% to 22.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.78%, marking a year-over-year decrease of 61100.0%. This contributed to the annual value of 24.6% for FY2024, which is 23500.0% down from last year.
  • Per National Research's latest filing, its EBITDA Margin stood at 24.6% for FY2024, which was down 23500.0% from 26.95% recorded in FY2023.
  • In the past 5 years, National Research's EBITDA Margin ranged from a high of 33.98% in FY2021 and a low of 24.6% during FY2024
  • Its 5-year average for EBITDA Margin is 29.65%, with a median of 30.71% in 2022.
  • As far as peak fluctuations go, National Research's EBITDA Margin soared by 19600bps in 2021, and later plummeted by -37600bps in 2023.
  • Annual analysis of 5 years shows National Research's EBITDA Margin stood at 32.02% in 2020, then rose by 6bps to 33.98% in 2021, then fell by -10bps to 30.71% in 2022, then dropped by -12bps to 26.95% in 2023, then decreased by -9bps to 24.6% in 2024.
  • Its last three reported values are 24.6% in FY2024, 26.95% for FY2023, and 30.71% during FY2022.